Rockwell Medical, Inc.
RMTI
$0.80
-$0.04-4.99%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -31.76% | -23.60% | -6.79% | 12.82% | 21.38% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -31.76% | -23.60% | -6.79% | 12.82% | 21.38% |
| Cost of Revenue | -31.48% | -21.98% | -11.18% | 3.63% | 12.14% |
| Gross Profit | -33.11% | -31.54% | 21.51% | 90.45% | 100.87% |
| SG&A Expenses | -2.79% | 1.89% | 10.64% | 13.43% | 18.15% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -26.70% | -18.25% | -8.42% | 4.26% | 11.74% |
| Operating Income | -871.55% | -929.66% | 58.23% | 108.71% | 109.12% |
| Income Before Tax | -1,007.08% | -346.28% | 56.01% | 96.86% | 94.31% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -1,007.08% | -346.28% | 56.01% | 96.86% | 94.31% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -1,007.08% | -346.28% | 56.01% | 96.86% | 94.31% |
| EBIT | -871.55% | -929.66% | 58.23% | 108.71% | 109.12% |
| EBITDA | -189.63% | -194.80% | 201.24% | 157.96% | 153.35% |
| EPS Basic | -340.63% | -176.53% | 55.64% | 94.60% | 92.38% |
| Normalized Basic EPS | -677.95% | -212.39% | 65.76% | 98.10% | 95.66% |
| EPS Diluted | -272.43% | -157.76% | 51.03% | 92.68% | 90.81% |
| Normalized Diluted EPS | -610.79% | -201.46% | 65.06% | 97.61% | 95.25% |
| Average Basic Shares Outstanding | 15.81% | 14.45% | 14.57% | 26.09% | 45.24% |
| Average Diluted Shares Outstanding | 13.57% | 12.16% | 13.77% | 28.49% | 48.10% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |